Libytec Pharmaceutical S.A.
Libytec Pharmaceuticals Ltd. represents an altogether different, new concept in the healthcare field, as a response to contemporary demands and needs. It was founded in June 2008, with the aim of providing reliable healthcare suggestions concerning modern pharmaceuticals, and boasts a remarkable portfolio of medical products, in many pharmacologic classes and categories.
Our presence in the Greek market has ensured high quality medicinal products, of high therapeutic value, as well as substances that stand out in their pharmacologic class. All products of the company are approved, produced, and distributed in accordance with current European standards and legislation, and always manage to earn the trust of patients and healthcare professionals alike. We focus on therapeutic categories that include cardiometabolic diseases, affections of the skin, and musculoskeletal disorders.
We support and potentiate the co-promotion of well-established products in collaboration with multinational companies. At the same time, we invest in research and development of innovative products available on the Greek market, many of which are already accompanied by their own studies.
Libytec Pharmaceuticals, through its continuous efforts in product development and in the search for important strategic partnerships, wishes to be in the forefront of companies that contribute to the Greek economy, and to provide young scientists with an employment potential ultimately aiming at the benefit and welfare of the Greek patient.